Published in J Virol on September 01, 1992
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J (2002) 1.27
The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo. J Biol Chem (2009) 1.04
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer (2011) 0.95
Identification of transforming hepatitis B virus S gene nonsense mutations derived from freely replicative viruses in hepatocellular carcinoma. PLoS One (2014) 0.80
Transactivation of proto-oncogene c-Myc by hepatitis B virus transactivator MHBs(t167.) Oncol Lett (2014) 0.75
Screening of hepatocyte proteins binding with C‑terminally truncated surface antigen middle protein of hepatitis B virus (MHBst167) by a yeast two‑hybrid system. Mol Med Rep (2014) 0.75
Study of transactivating effect of pre-S2 protein of hepatitis B virus and cloning of genes transactivated by pre-S2 protein with suppression subtractive hybridization. World J Gastroenterol (2005) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
The hepatitis B virus. Nature (1985) 8.71
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol (1988) 3.04
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
New light on Myc and Myb. Part II. Myb. Genes Dev (1990) 2.57
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Evidence for the double-strand break repair model of bacteriophage lambda recombination. Proc Natl Acad Sci U S A (1990) 2.20
Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol (1987) 2.18
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A (1989) 1.77
The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev (1987) 1.76
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature (1990) 1.69
The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J Virol (1990) 1.68
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene (1988) 1.54
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line. J Virol (1985) 1.39
Protein truncation is required for the activation of the c-myb proto-oncogene. Mol Cell Biol (1991) 1.26
The structure of hepatitis B surface antigen and its antigenic sites. Bioessays (1987) 1.19
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol (1988) 1.07
Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA. EMBO J (1984) 1.06
Integration of hepatitis B virus DNA in chromosome-specific satellite sequences. J Virol (1986) 1.05
Free and integrated forms of hepatitis B virus DNA in human hepatocellular carcinoma cells (PLC/342) propagated in nude mice. J Virol (1987) 0.91
Integration of hepatitis B virus: analysis of unoccupied sites. J Virol (1987) 0.87
Analysis of six distinct integrated hepatitis B virus sequences cloned from the cellular DNA of a human hepatocellular carcinoma. Virology (1986) 0.85
Hepatitis B virus surface antigen as a reporter of promoter activity. Gene (1989) 0.79
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Transformation of monocytes in tissue culture into macrophages, epithelioid cells, and multinucleated giant cells. An electron microscope study. J Cell Biol (1966) 4.74
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med (2000) 3.95
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
Women's attitudes toward gynecologic practices. Obstet Gynecol (1979) 3.52
Inhibition of minicircular DNA replication in Escherichia coli 15 by rifampicin. Nat New Biol (1972) 3.10
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A (1985) 2.67
Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet (1994) 2.29
CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol (1995) 2.28
Isolation and characterization of a ribonuclease 3 deficient mutant of Escherichia coli. Mol Gen Genet (1973) 2.19
Head rotation during internal jugular vein cannulation and the risk of carotid artery puncture. Anesth Analg (1996) 2.19
Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli. Nature (1981) 2.14
In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A (1987) 2.05
[Idiopathic CD4 lymphocytopenia]. Presse Med (1994) 2.03
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS (2000) 1.97
The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes. J Exp Med (1998) 1.91
Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell (1983) 1.87
Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant (1994) 1.80
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Res (2001) 1.79
Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. Science (1982) 1.78
Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr (1976) 1.77
Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol (1989) 1.77
Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J Infect Dis (2001) 1.76
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature (1990) 1.69
Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet (1994) 1.66
The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet (1983) 1.64
Uber infektiöse Substrukturen aus Escherichia coli Bakteriophagen. VII. Formation of a biologically intact replicative form in ribonucleic acid bacteriophage (M12)-infected cells. J Mol Biol (1966) 1.63
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. HIV Med (2008) 1.63
Appearance of beta-lactamase activity in animal cells upon liposome-mediated gene transfer. Gene (1980) 1.63
Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS (1998) 1.62
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology (1995) 1.62
Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am J Hum Genet (1997) 1.62
P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med (2000) 1.61
The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase. Int J Cancer (1974) 1.61
Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr (1990) 1.59
Infectious nucleic acids of e. Coli bacteriophages, ix. Sedimentation constants and strand integrity of infectious m12 phage replicative-form RNA. Proc Natl Acad Sci U S A (1966) 1.58
Diversity of surface layers in L-forms of Proteus mirabilis. J Gen Microbiol (1968) 1.57
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene (1988) 1.54
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Ultrastructural changes of endothelium associated with thrombocytopenia. Blood (1975) 1.53
Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol (1985) 1.52
An experimental evaluation of theory-based mother and mother-child programs for children of divorce. J Consult Clin Psychol (2000) 1.51
The role of the sinus wall in the passage of erythrocytes through the spleen. Blood (1973) 1.50
Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev (2000) 1.47
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A (1992) 1.47
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol (1990) 1.46
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest (1989) 1.45
Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases. Am J Gastroenterol (1985) 1.45
Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler (1986) 1.45
Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr (2001) 1.44
Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol (1998) 1.43
Colloidal iron hydroxide-binding to the surfaces of chick embryo fibroblasts transformed by wild-type and a temperature-sensitive mutant of Rous sarcoma virus. J Cell Physiol (1977) 1.43
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43
Night backache in pregnancy. Hypothetical pathophysiological mechanisms. Am J Phys Med Rehabil (1989) 1.42
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med (1988) 1.41
Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant (1993) 1.39
Neuraminidase, sialic acids, and cell interactions. J Natl Cancer Inst (1973) 1.38
Detection of tumors in soft tissues by ultrasonic holography. Surg Gynecol Obstet (1969) 1.38
Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12. Eur J Biochem (1967) 1.37
Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel. Emerg Infect Dis (2001) 1.37
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet (1999) 1.35
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency. Gastroenterology (1996) 1.32
The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology (1996) 1.32
Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gut (2001) 1.32
The origin of inverted tandem duplications, and phenotypic effects of tandem duplication of the X chromosome long arm. Am J Med Genet (1983) 1.31
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet (1984) 1.31
Karyotypic and surface features of murine TA3 carcinoma cells during immunoselection in mice and rats. J Natl Cancer Inst (1971) 1.31
The cell periphery. Int Rev Cytol (1969) 1.31
Toriello-Carey syndrome: evidence for X-linked inheritance. Am J Med Genet (1996) 1.31
Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer (1988) 1.30
Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene (1995) 1.29
Large-scale preparations of viruses by steric chromatography on columns of controlled pore glass. Phi-X174, M13, M12, Q-beta and T4 bacteriophages. Biochim Biophys Acta (1969) 1.29
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A (1990) 1.27
CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol (2000) 1.27
Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Acta Physiol Scand (1974) 1.27
The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice. Int J Cancer (1976) 1.27
Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol (1981) 1.26
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26
Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand (1970) 1.25
Mutant of phi X174 accessible to host-controlled modification. J Virol (1969) 1.25
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Gene order of RNA bacteriophage M 12. Nature (1970) 1.24
Deoxyribonucleic acid-envelope complexes isolated from Escherichia coli by free-flow electrophoresis: biochemical and electron microscope characterization. J Bacteriol (1974) 1.24
Regulation of the mammalian pyruvate dehydrogenase complex by covalent modification. Symp Soc Exp Biol (1973) 1.24
Variant angina of Prinzmetal with normal coronary arteriograms. A variant of the variant. Circulation (1973) 1.24
West Nile fever in Israel 1999-2000: from geese to humans. Ann N Y Acad Sci (2001) 1.23
Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood (1970) 1.22
[A structured pain interview for geriatric patients]. Schmerz (2001) 1.22
Activation of pyruvate dehydrogenase during metabolism of ammonium ions in hemoglobin-free perfused rat liver. Eur J Biochem (1975) 1.21
Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol (1996) 1.21
The hematopoietic microenvironment of the bone marrow: an ultrastructural study of the stroma in rats. Anat Rec (1976) 1.21
Expression of hepatitis B surface antigen in unselected cell culture transfected with recircularized HBV DNA. EMBO J (1982) 1.21